BioMed Research International / 2020 / Article / Tab 1

Research Article

L1CAM High Expression Associates with Poor Prognosis in Glioma but Does Not Correlate with C11orf95-RELA Fusion

Table 1

Clinicopathological characteristics in relation to L1CAM expression.

TotalL1CAML1CAM
NegativePositive

Total565456(80.71%)109(19.29%)
Gender0.400
  Male323259(80.19%)64(19.81%)
  Female242197(81.40%)45(18.60%)
Age0.006
  <=45343289(84.26%)54(15.74%)
  >45222167(75.23%)55(24.77%)
Location0.583
  Supratentorial517413(79.88%)104(20.12%)
  Subtentorial4843(89.58%)5(10.42%)
WHO grade0.371
  Low-grade (I and II)197161(81.73%)36(18.27%)
  High-grade (III and IV)368295(80.16%)73(19.84%)
IDH0.260
  Mutated240196(81.67%)44(18.33%)
  Wildtype325260(80.00%)65(20.00%)
ATRX0.003
  Mutated239215(89.96%)24(10.04%)
  Wildtype326241(73.93%)85(26.07%)
P530.181
  <=10%245193(78.78%)52(21.22%)
  >10%320263(82.19%)57(17.81%)
Ki670.007
  <=10%194168(86.60%)26(13.40%)
  >10%371288(77.63%)83(22.37%)

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.